✦ LIBER ✦

Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma

✍ Scribed by G. Hopfinger; R. Heinz; E. Koller; B. Schneider; E. Pittermann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide and etoposide as salvage ther

✍ Cavallin-Stahl, Eva ;Lind, Jack ;Hagberg, Hans 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 257 KB

Salvage therapy with etoposide, ifosfami

✍ B. Steinke; F. W. Busch; M. Heim; H. Arnold 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

Salvage therapy for non-Hodgkin's lympho

✍ Nissim Haim; Edward Rosenblatt; Mira Wollner; Menachem Ben-Shahar; Ron Epelbaum; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 236 KB

1022 Dexamethasone, etoposide, ifosfamid

✍ Haim, N.; Agbarya, A.; Leitzin, L.; Ben-Shachar, M.; Epelbaum, R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Mitoxantrone and high-dose cytarabine as

✍ Anthony D. Ho; Fransisco Del Valle; Heide Rückle; Jürgen Schwammborn; Günter Sch 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Ifosfamide, etoposide, cytarabine, and m

✍ Aspasia Stamatoullas; Christophe Fruchart; Dominique Bastit; Dominique Boulet; M 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB